Today on Outsourcing-Pharma.com   Bayer, Biocon discuss potential R&D and outsourcing deal Eli Lilly: drug safety revolution 'within our grasp' Genzyme gets slapped on the wrist by FDA Big pharma enters stem cell domain to address safety, attrition SAFC bets on drug conjugates with new manufacturing suite

Related Industry News   Granulation technology launched Investors jump into PDL stock in hope of imminent buyout Sperm stopped in their tracks by vaginal gel contraceptive BMS takeover speculation mounts, again

Breaking News on Outsourcing Pharma
Daily  Thursday 04 October 2007		Forward to a colleague

	Sponsored Link Introducing Catalent Pharma Solutions Catalent Pharma Solutions is the leading provider of advanced technologies as well as development, manufacturing and packaging services for pharmaceutical, biotechnology and consumer health companies in nearly 100 countries... Click Here Access Full Stories Bayer, Biocon discuss potential R&D and outsourcing deal German pharma firm Bayer is currently discussing with Indian company Biocon about a potential deal that would include the co-development of new biologics with an outsourcing element, according to Biocon... Read Eli Lilly: drug safety revolution 'within our grasp' The head of Eli Lilly has called for a reform of the US drug safety system, saying that an information revolution is 'within our grasp'... Read Genzyme gets slapped on the wrist by FDA The US Food and Drug Administration (FDA) has sent a letter to Genzyme to warn it about manufacturing issues at its biomanufacturing facility in Lyon, France... Read Big pharma enters stem cell domain to address safety, attrition Three of the world's biggest pharmaceutical companies have signed a landmark deal with the UK government that will see them use stem cell technology to road-test the safety of new compounds... Read SAFC bets on drug conjugates with new manufacturing suite SAFC has announced its plans to build a new high potency conjugation suite at its Missouri manufacturing plant in order to target pharma clients developing novel anti-cancer drug conjugates... Read
	All News Headlines for: October | September | August
	Company Profile DPT - The Industry Source for Semi-solids and Liquids. DPT is a contract development and manufacturing organization (CDMO) specializing in semi-solid and liquid dosage forms providing solutions from concept to commercialization. Click here to meet with DPT at CPhI/ICSE... Click Here
	Related Industry News Granulation technology launched Finland-based Atacama Labs has launched its proprietary technology system for developing solid oral dosage forms... Read Investors jump into PDL stock in hope of imminent buyout Furious trading in shares of PDL BioPharma has taken place over the past couple of days as investors jumped in with both pockets open in the hope that a partner will soon be in the offing for the ailing firm... Read Sperm stopped in their tracks by vaginal gel contraceptive Forget diamonds, a new vaginal gel contraceptive could be the 21st Century girl's new best friend with the ability to be applied up to 18 hours before a naughty rendezvous... Read BMS takeover speculation mounts, again Investors in Bristol-Myers Squibb were in a frisson of excitement earlier this week as speculation mounted - not for the first time - that the firm could soon become the target of a major pharmaceutical acquisition... Read Inside India: special series Clinical trials in India: 'The wind is blowing' An industry veteran gives Outsourcing-Pharma.com an update on the state of the contract research organisation (CRO) industry in India. Read Previous Headlines CRO supremacy in clinical research raises concerns While contract research organisations (CROs) now dominate the clinical trials market, questions are being raised about the risks of 'commercialising' clinical studies, according to new research... Read Sprinkles help the medicine go down US regulators have found a new 'hundreds and thousands'-like drug treatment to be very palatable... Read Recordati adopts Orphan Europe Eighty-year-old Italian pharma company Recordati believes its future lies in rare diseases and has put its money where its mouth is by spending €135m on speciality firm Orphan Europe... Read 'In-house' outsourcing firm in line for EU accolade Synergy has been short-listed in three categories for the upcoming European Outsourcing Awards - an accolade that could give a boost to its innovative "in house" outsourcing model... Read Drug theft costs industry up to $1bn a year Pharmaceutical companies not only have to face the consequences of a burgeoning counterfeit drug black market but have to contend with the theft of their own manufactured drugs for illicit uses, according to a... Read Product Innovation Alerts - Free of Charge Indicate your research interests and receive alerts on relevant products and market innovations Analytical testing, QC Bulk ingredients Contract sales & marketing Data management Drug delivery, formulation Fill & finish, packaging Phase I-II Phase III-IV Preclinical Product & Supplier News - Contract Manufacturing Regulatory affairs Supply chain, logistics Validation services

	Free Newsletters for Pharmaceuticals Access now !Choose from over 20 industry e-newsletters Access Decision News Media e-newsletters for the food, beverage & nutrition industries, click here
	Forward to a colleague

	To continue to receive this newsletter in your inbox, please add newsletter@OutSourcing-Pharma.com to your address book
	Update preferences | Change your email address | Unsubscribe
	Contact us: Advertising | Recruitment | Privacy policy | Terms & conditions | Feedback
	© 2007 - Decision News Media S.A.S - All Rights Reserved Le Belem - 355, rue Vendemiaire - 34000 Montpellier - France http://www.decisionnewsmedia.com